Pneumotox » Drug » Drug

List All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Ambrisentan

I.y

1

Amifostine

X.f

1

Aminoglutethimide

I.c I.l

1

Aminoglycoside antibiotics

IX.a

2

Aminorex

VI.b

4

Amiodarone

I.a I.b I.c I.d I.f I.g I.h I.k I.l I.r I.s I.w I.z I.ac II.b III.a III.c IV.a IV.d V.a V.c V.d VIII.a X.d X.f XI.c XI.o XI.u XII.c XII.v XV.d XV.f XV.g XV.k XV.m XV.o XV.r XVI.b XVI.s XIX.f

5

Amitriptyline

I.c II.b IX.d X.a

2

Amlodipine

II.a II.b IV.d VIII.a XI.b

2

Amoxapine

II.b

1

Amphetamines

II.a II.b VI.b

3

Amphotericin B

I.d II.a II.b IV.a VI.e VIII.c X.f X.g XI.b XV.ac

2

Ampicillin

I.c I.e II.b XV.b

1

Amrinone-Inamrinone

I.b V.m

1

Amrubicin

I.a

1

Amyl-, butyl-, isobutyl-nitrite

VIII.d XI.a XIV.a

3

Anabolic steroids

I.j II.b X.u

1

Anagrelide

I.a I.b

1

Anakinra

X.f XI.e

1

Anastrozole

VI.a

1

Angiotensin II receptor blockers-ARB

IV.d VIII.a

2

Anidulafungin

II.a II.i

1

Anorexigens-Anorectics

VI.b XII.b

4

Antazoline

I.b

1

Anthracyclines

XII.a XII.f

3

Antibiotics

X.f X.s XI.n

3

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

Legend Patterns
?

- I -
  Parenchymal lung disease
- - I.a Acute ILD
  - I.b Subacute ILD
  - I.c Eosinophilic pneumonia (PIE)
  - I.d Organizing pneumonia (OP)
  - I.e Acute eosinophilic pneumonia (AEP)
  - I.f Acute fibrinous organizing pneumonia (AFOP)
  - I.g Pulmonary fibrosis
  - I.h Subclinical ILD
  - I.i Diffuse pulmonary calcification
  - I.j Exogenous lipoid pneumonia
  - I.k Lung nodule or nodules
  - I.l Diffuse alveolar damage (DAD)
  - I.m ILD with a granulomatous component
  - I.n Pulmonary alveolar proteinosis (PAP)
  - I.o Localized pulmonary fibrosis
  - I.p Interstitial foreign body reaction/granulomas
  - I.q Pulmonary nodulosis
  - I.r Endogenous lipoid pneumonia (phospholipidosis)
  - I.s A mass or masses
  - I.t Pneumoconiosis-talcosis
  - I.u 'Recall' radiation pneumonitis
  - I.v Subclinical changes in PFTs
  - I.w Rapidly progressive pulmonary fibrosis
  - I.x Biapical fibrosis
  - I.y Exacerbation of preexisting ILD or fibrosis
  - I.z Areas of consolidation
  - I.aa Deterioration of pulmonary LAMM
  - I.ab Radiation-induced lung injury (RILI)
  - I.ac Relapsing pneumonitis
- II -
  Pulmonary edema - ALI - ARDS
- - II.a Noncardiogenic pulmonary edema - NCPE
  - II.b ALI - ARDS
  - II.c ARDS and the hemolytic-uremic syndrome
  - II.d Cardiogenic pulmonary edema
  - II.e Transfusion-related ALI (TRALI)
  - II.f Isolated hypoxemia/arterial desaturation
  - II.g Negative pressure pulmonary edema
  - II.h Overload pulmonary edema
  - II.i Flash pulmonary edema
  - II.j Transient pulmonary opacities
  - II.k The ATRA syndrome
- III -
  Pulmonary hemorrhage
- - III.a Diffuse alveolar hemorrhage - DAH
  - III.b Pneumorenal syndrome
  - III.c Hemoptysis
  - III.d ANCA-associated DAH
  - III.e Pulmonary hematoma
- IV -
  Airway involvement
- - IV.a Bronchospasm - wheezing - asthma
  - IV.b Bronchospasm and angioedema
  - IV.c Obliterative bronchiolitis
  - IV.d Lone cough
  - IV.e Acute violent coughing
  - IV.f Severe or catastrophic bronchospasm
  - IV.g Respiratory bronchiolitis ILD (RB-ILD)
  - IV.h Tracheobronchial necrosis
  - IV.i Foreign body bronchiolitis - Diffuse aspiration bronchiolitis
  - IV.j Calcification of cartilaginous rings
  - IV.k Bronchiectasis
  - IV.l Bronchial stump dehiscence
  - IV.m Bronchial stricture/stenosis
  - IV.n Obstructive airway dysfunction
  - IV.o Airway hyperresponsiveness
  - IV.p Thermal, chemical or caustic airway injury
  - IV.q Reactive airway dysfunction syndrome (RADS)
- V -
  Pleural and/or pericardial involvement
- - V.a Pleural effusion, lone
  - V.b Eosinophilic pleuritis/effusion
  - V.c Pleural thickening/fibrosis
  - V.d Pleural and/or pericardial effusion and the lupus syndrome
  - V.e Serosanguineous effusion - Hemothorax
  - V.f Pneumothorax
  - V.g The ovarian hyperstimulation syndrome (OHSS)
  - V.h Chylothorax
  - V.i Acute pleuropulmonary reaction
  - V.j Subpleural fat deposits
  - V.k Pleural calcifications
  - V.l Malignant mesothelioma
  - V.m Pleuro-pericardial effusion
  - V.n Bloody pericardial effusion - Hemopericardium
  - V.o Acute pleuric chest pain
  - V.p Pleuroparenchymal fibroelastosis
  - V.q Empyema
  - V.r Pleural mass or masses
  - V.s Polyserositis
- VI -
  Pulmonary vasculopathy
- - VI.a Pulmonary thromboembolism
  - VI.b Pulmonary arterial hypertension
  - VI.c Pulmonary veno-occlusive disease
  - VI.d Pulmonary vasculitis/capillaritis
  - VI.e Lipid/fat embolism
  - VI.f The hemolytic-uremic syndrome
  - VI.g Foreign body pulmonary vasculopathy
  - VI.h Acrylic cement embolism
  - VI.i Acute pulmonary hypertension
  - VI.j Mercury embolism
  - VI.k Eosinophilic pulmonary vasculitis
  - VI.l Acute pulmonary vasoconstriction and consequent PHTn
  - VI.m Silicone pulmonary embolism
  - VI.n Crystal pulmonary embolism
  - VI.o Air embolism (right-sided)
  - VI.p Angiomatoid pulmonary vasculopathy
  - VI.q Rebound pulmonary hypertension
  - VI.r Septic pulmonary emboli
  - VI.t Pulmonary artery aneurysm
  - VI.u Pulmonary microthrombi
  - VI.v Foreign body embolism
- VII -
  Mediastinal involvement
- - VII.a Lymphadenopathy
  - VII.b Lymphadenopathy with reactive changes
  - VII.c Mediastinal lipomatosis
  - VII.d Fibrosing mediastinitis
  - VII.e Granulomatous lymphadenopathy
  - VII.f Enlarged thymus
  - VII.g Mediastinal bleeding/hemorrhage
  - VII.h Pneumomediastinum
  - VII.i Mediastinitis
  - VII.j Compression of mediastinal organs
  - VII.k Mediastinal infiltration
- VIII -
  Central/large airway involvement/closure
- - VIII.a Angioedema
  - VIII.b Airway hematoma causing UAO
  - VIII.c UAO other than angioedema or hematoma
  - VIII.d Thermal, chemical or caustic airway injury
  - VIII.e Laryngospasm
  - VIII.f Central airway instability/malacia
  - VIII.g Tracheal narrowing - Sabre sheath trachea
  - VIII.h Vocal cord dysfunction, adduction or closure
  - VIII.i Midline destructive lesions
  - VIII.j Dysphonia
  - VIII.k Airway fire/explosion
  - VIII.k Submucosal tracheal bleeding
  - VIII.m Drug-associated airway foreign body
  - VIII.o Perforation of the nasal septum
  - VIII.q Tongue involvement
- IX -
  Neuromuscular involvement
- - IX.a Respiratory muscle weakness or paralysis
  - IX.b Respiratory dyskinesia
  - IX.c Chest wall/muscle rigidity
  - IX.d Ventilatory depression - Apnea
  - IX.e Disordered breathing during sleep
  - IX.f Hiccup
  - IX.g Myopathy of respiratory muscles
  - IX.h Isolated dyspnea
- X -
  Systemic reactions or conditions
- - X.a DRESS
  - X.b Antiphospholipid antibody syndrome (APLS)
  - X.c Vascular/capillary leak syndrome
  - X.d Drug-induced lupus
  - X.e Autoimmunity
  - X.f Anaphylaxis
  - X.g Hypersensitivity reaction
  - X.h Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
  - X.i Immune reconstitution syndrome - IRS/IRCS
  - X.j Myopathy - Myositis
  - X.k Sarcoid-like disease
  - X.l Subclinical ANA
  - X.m Systemic vasculitis
  - X.n Tumor lysis syndrome
  - X.o Sweet syndrome
  - X.p Serum sickness-like reaction
  - X.q Systemic inflammatory response
  - X.r Fluid retention
  - X.s ANCA-related disease or vasculitis
  - X.t Jarisch-Herxheimer reaction
  - X.u MOF/MODS
  - X.v Systemic eosinophilic syndrome
- XI -
  Miscellaneous
- - XI.a Cyanosis, low SpO2 and a normal measured PaO2
  - XI.b Acute non-pleuritic chest pain/tightness/pressure
  - XI.c Acute pleuritic chest pain
  - XI.d Metabolic acidosis
  - XI.e Opportunistic pulmonary infection
  - XI.f Opportunistic airway infection
  - XI.g Aspiration pneumonia
  - XI.h Addictive risk
  - XI.i Isolated hypercapnea
  - XI.j Vertebral compression fracture
  - XI.k Rib hypertrophy, periostitis
  - XI.l Pharmacobezoar
  - XI.m Pulmonary emphysema - Lung bullae
  - XI.n Neutropenia - Agranulocytosis
  - XI.o Cavitary pulmonary opacities
  - XI.p Pneumocystis jiroveci pneumonia
  - XI.q Pneumocystis jiroveci colonization
  - XI.r Death from inhalation of compound
  - XI.s Tumoral cavitation
  - XI.t Lung abscess or abscesses
  - XI.u Pseudocyanotic skin discoloration
  - XI.v Mycobacterial (M tuberculosis-NTM-BCG) intrathoracic disease
  - XI.w Chest deformity - Platythorax
  - XI.x Lung compression from ascites
  - XI.y Death from overdose
  - XI.z Cutaneous vasculopathy (occlusive or vasculitic)
  - XI.aa Fire-eater's lung
  - XI.ab Yellow nail syndrome
  - XI.ac Chronic chest or musculoskeletal pain
  - XI.ad Rib fracture
  - XI.ae Esophageal tear/rupture: Boerhaave syndrome
  - XI.af Esophageal ulceration/stenosis/stricture
  - XI.ag Localized chest pain
  - XI.ah Superior vena cava syndrome
- XII -
  Heart/circulatory involvement
- - XII.a Left ventricular failure
  - XII.b Valvular heart disease
  - XII.c Pericardial effusion or tamponade
  - XII.d Myocarditis
  - XII.e Tako-tsubo cardiomyopathy
  - XII.f Cardiomyopathy
  - XII.g Acute coronary syndrome - Myocardial infarction
  - XII.h Eosinophilic myocarditis
  - XII.i Endocarditis
  - XII.j Myocardial stunning
  - XII.k Pericardial thickening/constriction
  - XII.l Arrhythmias - Dysrhythmias
  - XII.m Cardiopulmonary arrest
  - XII.n Hypotension, cardiovascular collapse, shock
  - XII.o Coronary artery disease
  - XII.p Long QT syndrome
  - XII.r Coarctation of the aorta (acquired)
  - XII.r Congestive heart failure
  - XII.s Heart block
  - XII.t 'Torsades de pointe'
  - XII.u Left atrial/ventricular thrombosis
  - XII.v Arterial hypotension
  - XII.w Hypertrophic cardiomyopathy
- XIII -
  Neoplasias - Neoplasms
- - XIII.a Solid tumors including lung cancer
  - XIII.b Lymphoproliferative disease
  - XIII.c Leukemia
  - XIII.d Malignant mesothelioma
- XIV -
  Hemoglobinopathies, acquired
- - XIV.a Methemoglobinemia
  - XIV.b Sulfhemoglobinemia
  - XIV.c Carboxyhemoglobinemia
  - XIV.d Interference with COHb measurement
  - XIV.e Interference with SpO2 measurement
- XV -
  Pathology
- - XV.a Path: Cellular ILD - NSIP-pattern
  - XV.b Path: Eosinophilic pneumonia (subacute or acute)
  - XV.c Path: Organizing pneumonia pattern
  - XV.d Path: Acute fibrinous organizing pneumonia, AFOP-pattern
  - XV.e Path: ILD with a granulomatous component
  - XV.f Path: Diffuse alveolar damage (DAD) - Hyaline membranes
  - XV.g Path: Diffuse alveolar hemorrhage (DAH)
  - XV.h Path: Pulmonary fibrosis (NSIP/fibrotic-pattern)
  - XV.i Path: A reactive alveolar or bronchiolar epithelium
  - XV.j Path: UIP-pattern
  - XV.k Path: DIP-pattern
  - XV.l Path: GIP-pattern
  - XV.m Path: Lymphoid hyperplasia, LIP-pattern
  - XV.n Path: PAP-pattern - secondary PAP
  - XV.o Path: Endogenous lipoid pneumonia - phospholipidosis
  - XV.p Path: Exogenous lipoid pneumonia
  - XV.q Path: Interstitial foreign body deposits/reaction
  - XV.r Path: Smudged geographic necrosis
  - XV.s Path: Pneumoconiosis, talcosis, talcoma
  - XV.t Path: Pulmonary amyloid deposits
  - XV.u Path: Crystal storage disease
  - XV.u Path: Diffuse pulmonary calcification
  - XV.u Path: Pulmonary edema
  - XV.v Path: Subacute/acute cellular bronchiolitis
  - XV.w Path: RB-ILD
  - XV.x Path: Obliterative broncholitis
  - XV.y Path: Foreign body bronchiolitis
  - XV.z Path: Pulmonary capillaritis
  - XV.aa Path: Pulmonary vasculitis other than capillaritis
  - XV.ab Path: Eosinophilic vasculitis
  - XV.ac Path: Fat embolism
  - XV.ad Path: Silicone embolism/deposits
  - XV.ae Path: Foreign body microangiopathy/vasculopathy
  - XV.af Path: Elemental mercury embolism
  - XV.ag Path: Cement embolism
  - XV.ah Path: Crystal pulmonary embolism
  - XV.ai Path: Venoocclusive disease (PVOD)
  - XV.aj Path: Pulmonary hypertension incl. angiomatoid vasculopathy
  - XV.ak Path: Pleuritis n.o.s.
  - XV.al Path: Eosinophilic pleuritis
  - XV.am Path: Pleural fibrosis
  - XV.an Path: Pleuroparenchymal fibroelastosis
  - XV.ao Path: Kayexalate lung
  - XV.ap Path: Alveolar carbonaceous deposits
  - XV.aq Path: Fire eater's lung
  - XV.ar Path: Pulmonary microvascular granulocyte sequestration
  - XV.as Path: Deterioration of pulmonary LAMM
  - XV.at Path: Textiloma - Gossypiboma
  - XV.au Path: Occlusive skin vasculopathy
  - XV.av Path: Siliconoma
  - XV.aw Path: Smoking-related interstitial fibrosis (SRIF)
  - XV.ax Path: Lymphadenopathy with reactive changes
  - XV.ay Path: Granulomatous lymphadenopathy
  - XV.az Path: Eosinophilic bronchiolitis
  - XV.ba Path: Opportunistic pulmonary infection
  - XV.bb Path: Bronchiolar vasculitis and necrosis
  - XV.bc Path: Interstitial pulmonary edema
  - XV.bd Path: Pulmonary necrotizing granulomas
  - XV.be Path: Tracheal or bronchial wall ulceration
  - XV.bf Path: Foreign body reaction in large airway wall
- XVI -
  Imaging
- - XVI.a Imaging: Diffuse haze
  - XVI.b Imaging: Ground-glass opacities (GGO)
  - XVI.c Imaging: Mosaic pattern of attenuation
  - XVI.d Imaging: Batwing or butterfly pattern
  - XVI.e Imaging: Subpleural pulmonary opacities
  - XVI.f Imaging: Bibasilar opacities
  - XVI.g Imaging: Diffuse whiteout
  - XVI.h Imaging: Biapical or mid-lung opacities
  - XVI.i Imaging: Areas of involvement with a recognizable anatomic distribution
  - XVI.j Imaging: Wandering pulmonary opacities
  - XVI.k Imaging: Areas of consolidation
  - XVI.l Imaging: Peribronchovascular consolidation
  - XVI.m Imaging: Interlobular septal thickening
  - XVI.n Imaging: Intralobular septal thickening - Crazy paving
  - XVI.o Imaging: Localized ground-glass
  - XVI.p Imaging: Reticulation
  - XVI.q Imaging: An IPF-like imaging pattern
  - XVI.r Imaging: Areas of involvement with low attenuation numbers
  - XVI.s Imaging: Areas of involvement with high attenuation numbers
  - XVI.u Imaging: Diffuse random micronodules
  - XVI.v Imaging: Diffuse centrilobular micronodules
  - XVI.w Imaging: Multiple lung nodules
  - XVI.x Imaging: Halo sign
  - XVI.y Imaging: Reversed halo (Atoll) sign
  - XVI.z Imaging: A large nodule, nodules or masses
  - XVI.aa Imaging: Nodules, mass or masses with a central area of low attenuation
  - XVI.ab Imaging: Cavitary lung nodules
  - XVI.ac Imaging: XXX
  - XVI.ad Imaging: A calcified mass or masses
  - XVI.ae Imaging: Progressive massive fibrosis (PMF)
  - XVI.af Imaging: Lung bullae or cysts
  - XVI.ag Imaging: Pulmonary emphysema
  - XVI.ah Imaging: Pneumatoceles
  - XVI.ai Imaging: A tree-in-bud pattern
  - XVI.aj Imaging: Bronchiectasis
  - XVI.ak Imaging: Calcification of cartilaginous rings
  - XVI.al Imaging: Bronchial wall thickening
  - XVI.am Imaging: XXX
  - XVI.an Imaging: Pleural effusion
  - XVI.ao Imaging: Massive pleural effusion
  - XVI.ap Imaging: Pleural thickening
  - XVI.aq Imaging: Pneumothorax
  - XVI.ar Imaging: Hydropneumothorax
  - XVI.as Imaging: Pleural mass or masses
  - XVI.at Imaging:
  - XVI.au Imaging:
  - XVI.av Imaging:
  - XVI.aw Imaging:
  - XVI.ax Imaging: Vasc
  - XVI.ay Imaging: Vasc
  - XVI.az Imaging: Vasc
  - XVI.ba Imaging:
  - XVI.bb Imaging: Pneumomediastinum
  - XVI.bc Imaging: Lymph node enlargement
  - XVI.bd Imaging:
  - XVI.be Imaging: Enlarged thoracic venous collaterals
- XVII -
  Infection
- - XVII.a Pneumonia n.o.s.
  - XVII.b Bacterial pneumonia
  - XVII.c Pulmonary aspergillosis
  - XVII.d Pneumocystis jiroveci colonization
  - XVII.e Pneumocystis jiroveci pneumonia
  - XVII.f Viral pneumonia
  - XVII.g Tuberculosis
  - XVII.h Pulmonary NTM infection
  - XVII.i BCG infection
  - XVII.j Pulmonary mucormycosis
  - XVII.k Bacterial colonization of the airways
  - XVII.l Fungal colonization of the airways
  - XVII.m Pseudomembranous Aspergillus tracheobronchitis
- XVIII -
  Distinctive signs and/or symptoms: eye catchers
- - XVIII.a x
  - XVIII.b x
  - XVIII.c x
  - XVIII.d x
  - XVIII.e x
  - XVIII.f x
  - XVIII.g x
  - XVIII.h x
  - XVIII.j x
  - XVIII.k Eye-catcher: Multiple radiolucent balls
  - XVIII.l Eye-catcher: Tongue edema
  - XVIII.m Eye-catcher: Acrylic cement embolism
  - XVIII.n Eye-catcher: Lipiodol pulmonary embolism
- XIX -
  Cytology (BAL, pleural fluid, FNA) - BAL fluid
- - XIX.a Cytology: Lymphocytic BAL
  - XIX.b Cytology: Neutrophilic BAL
  - XIX.c Cytology: Eosinophilic BAL
  - XIX.d Cytology: Hemorrhagic BAL
  - XIX.e Cytology: Stainable iron-laden macrophages in BALF
  - XIX.f Cytology: Foamy (phospholipidotic) macrophages (BALF, pleural fluid, FNA)
  - XIX.g Cytology: Atypical alveolar cells in BALF
  - XIX.h -
  - XIX.i Cytology: Multinucleated giant cells in BALF
  - XIX.j Free mineral oil in BALF
  - XIX.k Cytology: Talc crystals in macrophages or lying freely in BALF
- XX -
  Diagnostic criteria for DIRD